Kearns-Sayre Syndrome (KSS): Symptoms, Causes & Management

Kearns-Sayre Syndrome (KSS) is a rare mitochondrial DNA deletion syndrome (typically 4.9 kb deletion) with onset <20 years.

Diagnostic Triad (All Required)

  1. Onset <20 years
  2. Progressive external ophthalmoplegia (PEO): Ptosis, ophthalmoparesis
  3. Pigmentary retinopathy: "Salt-and-pepper" fundus

Plus ≥1 of: Cardiac conduction defects (CHB, BBB), cerebellar ataxia, CSF protein >100 mg/dL.

Multisystem Manifestations

  • Muscle: Weakness, exercise intolerance, proximal myopathy
  • Eyes: PEO, retinopathy, cataracts, ophthalmoplegia
  • Heart: Conduction defects (syncope, sudden death risk), cardiomyopathy
  • Endocrine: Diabetes mellitus, hypogonadism, hypothyroidism, short stature
  • Neurologic: Ataxia, seizures, dementia, hearing loss, neuropathy
  • Renal: Tubulopathy (Fanconi-like)

Genetics

Large-scale mtDNA deletions (usually sporadic, not maternal). Heteroplasmy level correlates with severity.

Management (Multidisciplinary)

  • Cardiac: Annual ECG/Holter; pacemaker/ICD for conduction disease (Class I indication).
  • Ophthalmologic: Ptosis surgery if vision obstructed; low-vision aids.
  • Endocrine: Screen/treat diabetes, thyroid, growth hormone.
  • Neurologic: Ataxia rehab; seizure control; CoQ10, idebenone, creatine (limited evidence).
  • Genetic counseling: Recurrence risk low (sporadic), but maternal transmission possible if mother has heteroplasmy.
  • Avoid mitochondrial toxins: Valproate, aminoglycosides, linezolid, excessive alcohol.

No cure, but proactive surveillance and symptomatic care improve quality of life and longevity.

Genetic Disorders - Related Articles